Moderna
MRNA
#1404
Rank
C$22.00 B
Marketcap
C$56.32
Share price
2.47%
Change (1 day)
13.89%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Moderna (MRNA) Fails to deliver data

Key failure to deliver metrics for Moderna :

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Moderna (MRNA) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Moderna (MRNA) - since 2018

Volume in USD (price x number of shares), data since 2018

Moderna (MRNA) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2025C$60.89 M-61.04%
2024C$0.15 B15.08%
2023C$0.13 B-50.15%
2022C$0.27 B-85.7%
2021C$1.90 B158.2%
2020C$0.73 B369.18%
2019C$0.15 B1011.49%
2018C$14.15 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Regulus Therapeutics
RGLS
N/AC$5.47 M๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$16.99 MC$0.16 B๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
C$0.09 MC$0.71 M๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
C$9.04 MC$42.05 M๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$49.62 MC$0.10 B๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Arrowhead Pharmaceuticals
ARWR
C$0.77 MC$7.63 M๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
C$55.75 MC$0.10 B๐Ÿ‡บ๐Ÿ‡ธ USA